Mark Esposito

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Venues

Nature communications

The Journal of experimental medicine

PLoS pathogens

Cancer research

Princeton University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Princeton University

United States

PHD :: Molecular Biology

Publications

Mark Esposito, John K Amory, Yibin Kang
The pathogenic role of retinoid nuclear receptor signaling in cancer and metabolic syndromes. The Journal of experimental medicine 221 (9) (2024)
Mark Esposito, John K Amory, Yibin Kang
The pathogenic role of retinoid nuclear receptor signaling in cancer and metabolic syndromes. The Journal of experimental medicine 221 (9) (2024)
Jinsook Son, Wen Du, Mark Esposito, Kaavian Shariati, Hongxu Ding, Yibin Kang, Domenico Accili
Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure. Nature communications 14 (1) (2023)
Jinsook Son, Wen Du, Mark Esposito, Kaavian Shariati, Hongxu Ding, Yibin Kang, Domenico Accili
Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure. Nature communications 14 (1) (2023)
Jinsook Son, Wen Du, Mark Esposito, Kaavian Shariati, Hongxu Ding, Yibin Kang, Domenico Accili
Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure. Nature communications 14 (1) (2023)
Jinsook Son, Wen Du, Mark Esposito, Kaavian Shariati, Hongxu Ding, Yibin Kang, Domenico Accili
Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure. Nature communications 14 (1) (2023)
Jinsook Son, Wen Du, Mark Esposito, Kaavian Shariati, Hongxu Ding, Yibin Kang, Domenico Accili
Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure. Nature communications 14 (1) (2023)
Jinsook Son, Wen Du, Mark Esposito, Kaavian Shariati, Hongxu Ding, Yibin Kang, Domenico Accili
Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure. Nature communications 14 (1) (2023)
Mark Esposito, Cao Fang, Katelyn C Cook, Nana Park, Yong Wei, Chiara Spadazzi, Dan Bracha, Ramesh T Gunaratna, Gary Laevsky, Christina J DeCoste, Hannah Slabodkin, Clifford P Brangwynne, Ileana M Cristea, Yibin Kang
TGF-β-induced DACT1 biomolecular condensates repress Wnt signalling to promote bone metastasis. Nature cell biology 23 (3) (2021)
Jonathan M Ghergurovich, Mark Esposito, Zihong Chen, Joshua Z Wang, Vrushank Bhatt, Taijin Lan, Eileen P White, Yibin Kang, Jessie Yanxiang Guo, Joshua D Rabinowitz
Glucose-6-Phosphate Dehydrogenase Is Not Essential for K-Ras-Driven Tumor Growth or Metastasis. Cancer research 80 (18) (2020)
Geoffrey D Vrla, Mark Esposito, Chen Zhang, Yibin Kang, Mohammad R Seyedsayamdost, Zemer Gitai
Cytotoxic alkyl-quinolones mediate surface-induced virulence in Pseudomonas aeruginosa. PLoS pathogens 16 (9) (2020)

Mark Esposito.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mark Esposito